4//SEC Filing
BLOCH LAWRENCE E 4
Accession 0000899243-18-000453
CIK 0001113148other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:05 PM ET
Size
8.2 KB
Accession
0000899243-18-000453
Insider Transaction Report
Form 4
BLOCH LAWRENCE E
EVP, CFO & CBO
Transactions
- Award
Common Stock
2018-01-02+37,881→ 626,133 total - Award
Stock Option (right to buy)
2018-01-02+100,000→ 100,000 totalExercise: $2.23Exp: 2028-01-02→ Common Stock (100,000 underlying)
Holdings
- 8,958.82(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Represents the reporting person's 2017 contingent compensation award paid in shares of common stock in lieu of cash at the election of the Compensation Committee of the issuer's Board of Directors.
- [F2]Includes 7,308 shares of common stock acquired by Dr. Bloch on December 15, 2017 through participation in the issuer's Employee Stock Purchase Plan.
- [F3]The option vests over a period of two years in equal annual installments on the first and second anniversary of the date of grant.
Documents
Issuer
INFINITY PHARMACEUTICALS, INC.
CIK 0001113148
Entity typeother
Related Parties
1- filerCIK 0001244822
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:05 PM ET
- Size
- 8.2 KB